Stay updated on Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T17:56:23.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a small maintenance update with no visible changes to study data.
    Difference
    0.1%
    Check dated 2026-03-11T14:04:04.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    System updates show Revision: v3.4.2 added and prior notices about funding and operating status (Revision: v3.4.1) present in the deletions. These changes relate to site maintenance and do not modify the trial record details, outcomes, or recruitment information; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T01:59:57.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the page to Revision: v3.4.1 (from v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-03T23:40:00.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Footer/UI updates add a 'Show glossary' option, adjust the 'No FEAR Act Data' label capitalization, and update the site revision from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-27T22:35:59.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Footer updates include the addition of Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link as well as the Revision: v3.3.2 reference. These changes do not affect the study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T08:23:23.000Z thumbnail image

Stay in the know with updates to Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial page.